Balaji Amines Limited
Balaji Amines Ltd specialises in manufacturing Methylamines, Ethylamines, Derivatives of specialty chemicals and Pharma Excipients. These have been the main products, it also have facilities for the manufacturing of derivatives, which are down-stream products for various pharma/pesticide industries apart from user specific requirements. It is one of the largest manufacturers of aliphatic amines in India.
What Balaji files
- Others52
- Investor Meet24
- Updates16
- Important12
- Board Meeting11
- PPTs9
Here's a concise summary of Balaji Amines' Q1 FY27 investor presentation: **1. Business Performance:** Balaji Amines commenced FY27 on a strong note, delivering healthy operational and financial performance with resilient margins. Its core chemical business continues to deliver a superior Return on Capital Employed (RoCE), reflecting strong fundamentals and manufacturing...
Balaji Amines delivered a strong Q4FY26 consolidated performance. Revenue rose to ₹403 Cr, up 19.9% QoQ and 11.7% YoY. EBITDA surged to ₹102 Cr, a 65.3% QoQ and 51.3% YoY jump, boosting EBITDA margin to 25%. Profit After Tax (PAT) more than doubled QoQ to ₹65 Cr, up 108.3%, and...
**1. Business Performance:** Balaji Amines saw Q3FY26 consolidated revenue of ₹336 Cr (+4.9% YoY), with volumes up to 25,894 MT, reflecting stable operations. However, 9MFY26 revenue slightly dipped 1.7% YoY to ₹1,051 Cr. **2. Growth Drivers or Strategy:** Focusing on high-value specialty chemicals, the company plans new DME, NMM, and...
**Business Performance:** Balaji Amines reported stable Q2FY26 performance, with consolidated revenue at ₹348 Cr, a slight dip from previous quarters. Total volumes remained steady at 26,165 MT, supported by consistent demand. H1FY26 saw consolidated revenue at ₹715 Cr (-5% YoY), EBITDA ₹131 Cr (-9% YoY), and PAT ₹74 Cr (-15%...
Here is the financial summary for Balaji Amines Limited: **1. Financial Highlights:** Consolidated Q1FY26 revenue was ₹367 Cr, up QoQ but down YoY. EBITDA & PAT declined sequentially and annually despite volume growth to 27,570 MT. Standalone results remained stable with ₹327 Cr revenue and ₹64 Cr EBITDA. **2. Strategic...